Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
Recruiting
Observational Study
Ph Positive ALL
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Group for Research in Adult Acute Lymphoblastic Leukemia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>= 18
* Relapse or refractory Ph1 ALL
Exclusion Criteria:
* none
Contacts